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Abstract
Recently, due to their unique properties, gold nanoparti‐
cles (AuNPs) have been used in many biological applica‐
tions. However, little is known about their toxicity when
they come into contact  with a  biological  system. Based
on the proposal that AuNPs can have a positive effect on
wound  healing,  the  present  study  investigated  the
influence of negatively-charged-surface AuNPs (average
diameter  25-50  nm)  on  the  viability  of  normal  human
dermal  fibroblasts  (NHDF)  and  normal  human epider‐
mal keratinocytes (NHEK). Moreover, we evaluated the
effect of AuNPs on the secretion of proteins involved in
wound healing, such as interleukin-8 and -12 (IL-8, IL-12),
tumour necrosis factor-alpha (TNF-α), vascular endothe‐
lial  growth  factor  (VEGF),  basic  fibroblast  grow  factor
(bFGF), and granulocyte-macrophage colony-stimulating
factor (GM-CSF).  The results  showed that AuNPs were
not toxic to NHDF and NHEK. They showed a decrease
in  AuNPs’  production  of  pro-inflammatory  cytokines
IL-6,  IL-12  and TNF-α,  as  well  as  proteins  involved in
angiogenesis  such  as  VEGF  and  bFGF.  Thus,  we  sug‐
gest that AuNPs could have anti-inflammatory and anti-
angiogenic activity.
Keywords Gold nanoparticles (AuNPs), Anti-inflammato‐
ry activity, Cytotoxicity, Cytokines
1. Introduction
Today, nanomaterials are of interest in many scientific
fields because they have important applications in a wide
variety of areas. They are already used in many commer‐
cially available products, such as cosmetics and sunscreens,
pharmaceuticals, sports equipment, dressings for wound
healing, etc. [1, 2]. Nanomaterials have excellent biological
properties, which can make them suitable for medical
purposes. In particular, nanomaterials can interact with
cellular proteins and organelles. These interactions can be
used for the development of new medical and pharma‐
ceutical materials [3].
AuNPs, due to their unique surface, electronic and optical
properties, have been often studied [4]. In recent years,
AuNPs have served as vehicles for gene delivery, in
biosensors, cancer-cell imaging and drug delivery [3, 5]. In
addition, it has been reported that AuNPs conjugated by
β-cyclodextrin and curcumin could be useful as therapeutic
agents for preventing and treating osteoporosis, as they
inhibit the formation of tartrate-resistant acid phosphatase
(TRAP)-positive multinuclear cells in bone marrow-
derived macrophages [6].
However, toxicological studies suggest that AuNPs may
cause adverse health effects [7]. Findings have shown that
AuNPs may penetrate unusually deep into skin and other
organs [8]. It has also been shown that the major pathway
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of 45 nm AuNPs is mediated by endocytosis and 13 nm
AuNPs by phagocytosis [9, 10]. Very small AuNPs (1 nm)
can penetrate both into cells and into nuclear membranes
[11]. However, the effects of AuNPs on cells are still unclear
[8]. It is important to focus on the study of cytotoxicity [12].
Many studies have reported non-toxicity of AuNPs [13,
14], but others have described a toxic effect on cells [7, 15].
It is known that metallic Au is not toxic, but gold chloride
or potassium gold cyanide is toxic to organs [16]. Lu et al.
(2010) investigated the effect of 34 nm AuNPs in different
concentrations on keratinocyte proliferation. It was shown
that low concentrations (5 ppm) could stimulate keratino‐
cyte proliferation but that higher concentration (>10 ppm)
could be toxic to keratinocytes [17].
It has been shown that AuNP sizes correlate to both the
secretion of pro-inflammatory cytokines and antibody
production. Spherical (40 nm) AuNPs stimulated pro-
inflammatory cytokines IL-6, IL-12 and TNF- α at a high
level. On the other hand, smaller spherical AuNPs (20 nm)
did not influence the production of cytokines [18]. It is also
well documented that drugs containing AuNPs have anti-
inflammatory activities, and, combined with antioxidants,
accelerate cutaneous wound healing through anti-inflam‐
matory and antioxidant effects [5, 19].
In this work, we tested the effect of spherical AuNPs
(average diameter 25-50 nm) on cell viability and on
biomarkers involved in wound healing on normal human





Keratinocyte basal medium-2 and KGM™-2 SingleQuots™
were purchased from East Port Prague s.r.o. (Czech
Republic). EpiLife® Medium and Human Keratinocyte
Growth Supplement Kits (HKGS) were purchased from
Life Technologies s.r.o. (Czech Republic). A human total
MMP-1 ELISA kit was purchased from R&D Systems
(USA). A development IL-6 ELISA kit and a development
IL-8 ELISA kit were purchased from Peprotech (UK). A Bio-
Plex Human Cytokines ELISA kit and a Bio-Plex 200
System were purchased from Bio-Rad (USA). Dulbecco’s
modified Eagle’s medium, Ham-F12 Nutrient Mixture,
heat-inactivated foetal calf serum, stabilized penicillin-
streptomycin solution, amphotericin B, hydrocortisone,
adenine, insulin, epidermal growth factor, 3,3',5-triiod-L-
thyronin, trypsin, ampicillin, amino acids (L-histidine, L-
isoleucine, L-methionine, L-tryptophan, L-tyrosine), 3-(4,5-
dimethylthiazol-2-yl)-2,5-diphenyltetrazolium bromide
(MTT) and all other chemicals were purchased from Sigma-
Aldrich (USA).
1.2 Methods
1.2.1 Preparation of AuNPs
The sample of AuNPs was obtained from NanoTrade
Company and prepared according to the Czech Patent No.
304 160 [20]. Conventional techniques for aqueous synthe‐
sis of AuNPs involve reduction of gold chloride (Au (III)
Cl3) with trisodium citrate. In this method, the citrate salt
initially acts as a reducing agent by forming a layer of citrate
ions over the AuNP surface, inducing enough electrostatic
repulsion between individual particles to keep them well
dispersed in the medium. Briefly, chloroauric acid
(HAuCl4) was heated to boil. Then, aqueous solution of 1%
trisodium citrate was added to the HAuCl4 solution under
vigorous stirring and the AuNPs were formed by crystal‐
lization. The citrate ions serve as reducing agent for AuNP
formation and as stabilizer, preventing agglomeration of
AuNPs.
1.2.2 Material Characterization
Analysis of AuNPs was performed on a JEOL JEM 2011
(JEOL, Tokyo, Japan) at accelerating voltage of 160 kV.
AuNPs had an average diameter of 25-50 nm (Fig. 1A). The
measurement of Zeta potential was performed using a
Brookhaven ZetaPlus Zeta Potential Analyzer (Artisan
Technology Group). AuNPs had a negative charge because
their Zeta potential was -23.4 mV. AuNPs stabilized with
citrate were characterized by transmission electron micro‐
scopy (TEM) (Fig. 1B). Photographs were taken using a
Keen View II digital camera using the program iTEM (SIS,
Olympus).
1.2.3 Cell Culture
The cells were isolated from the skin specimens, which
were removed during abdominoplasty or breast surgery of
healthy adult women with their written informed consent
and the approval of the Ethics Committee of the Faculty
Hospital in Olomouc.
Normal human dermal fibroblasts (NHDF): The samples of
skin were cut into pieces (approximately 1x1 cm), placed in
Petri dishes (10 cm diameter) and cultured in a mixture of
Dulbecco’s modified Eagle’s medium (DMEM) and Ham’s
F12 Nutrient Mixture (1:3) supplemented with 10% foetal
bovine serum (FBS), penicillin (100 mg/ml), streptomycin
(100 U/ml), amphotericin B (0.125 mg/ml), hydrocortisone
(0.8 µg/ml), adenine (24 µg/ml), insulin (0.12 U/ml),
epidermal growth factor (1 ng/ml), and 3,3',5-triiod-L-
thyronin (0.136 µg/ml). The skin pieces were incubated in
humidified atmosphere with 5% CO2 at 37°C. The medium
was changed every other day until the fibroblasts reached
confluence. After two to three weeks, cells were trypsinized
and transferred into 75 cm2 cultivation flasks. Cells were
cultivated in DMEM supplemented with 10% FBS, penicil‐
lin (100 mg/ml) and streptomycin (100 U/ml) at 37ºC in a
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5% CO2 atmosphere. Cells were used between splitting 2
and 3.
Normal human epidermal keratinocytes (NHEK): The samples
of skin were cut into pieces (approximately 2x3 cm), placed
into cold 0.5% trypsin solution and incubated overnight at
4ºC. After the incubation period, the epidermis and dermis
were separated using thin forceps and the epidermal tissue
was placed in the keratinocyte basal medium-2 (KBM-2)
supplemented with KGM™-2 SingleQuots™ and 2% FBS.
The epidermal cells were then dissociated mechanically by
stirring. The cell suspension was filtered through a cell
strainer and centrifuged (5 min, 1000 rpm, 4ºC). The pellet
was resuspended in KBM-2 supplemented with KGM™-2
and FBS and transferred into 75 cm2 cultivation flasks; cells
were then grown in humidified atmosphere for three days.
After the incubation period the KBM-2 supplemented with
KGM™-2 and FBS was altered by the EpiLife® growth
medium (EPIM) supplemented with a Human Keratino‐
cyte Growth Supplement Kit (HKGS), penicillin (100 mg/
ml), streptomycin (100 mg/l) and ampicillin (250 µg/ml) at
37ºC in a 5% CO2 atmosphere. The medium was changed
every other day until the keratinocytes reached 50-60%
confluence. Cells were used at splitting 3 [21].
1.2.4 Cell Viability
Cells were seeded on 96-well culture plates (NHDF at
concentration 1x105 cells/cm2, NHEK at concentration
8x103 cells/cm2). After 24 hrs, AuNPs diluted in serum-free
DMEM (NHDF; concentration range 0.01-25 ppm) and
serum-free EPIM (NHEK; concentration range 0.013-33
ppm) were applied to cells and incubated for 24 hrs.
Control cells were incubated in serum-free medium
without AuNPs. MTT assay was used to evaluate cell
survival. This assay is based on the ability of viable cells to
convert soluble methyl tetrazolium salts to insoluble
formazan. Formazan is quantitated by spectrophotometry
after being dissolved in dimethyl sulphoxide and ammo‐
nia. The absorbance was measured at 540 nm.
1.2.5 Wound Scratch Assay
The cells were seeded on six-well culture plates (NHDF at
concentration 5x105 cells/cm2, NHEK at concentration
3x104 cells/cm2) and cultivated to form a confluent mono‐
layer. Then, the cells were scratched with a sterile 10 ml
plastic pipette. The cells were washed with PBS and AuNPs
were added in non-toxic concentrations (0.25 ppm; 2.5
ppm; 25 ppm) diluted in corresponding serum-free
medium. The control cells were cultured in corresponding
serum-free medium without AuNPs.
After 24 and 48 hrs the cell supernatant was collected for
determination of interleukin-12 (IL-12), tumour necrosis
factor-alpha (TNF-α), basic fibroblast grow factor (bFGF),
vascular endothelial growth factor (VEGF) and granulo‐
cyte-macrophage colony-stimulating factor (GM-CSF) by
Bio-Plex analysis; matrix metalloproteinase-1 (MMP-1),
interleukin-6 (IL-6) and interleukin (IL-8) were determined
by ELISA kits. All markers were determined according to
manufacturer protocol.
1.2.6 Statistical Analysis
The results were expressed as mean ± SD of five independ‐
ent experiments. The differences in mean values were
analysed by Student’s t-test. *P < 0.05; **P < 0.01 or ***P <
0.001 were considered statistically significant.
3. Results and Discussion
The interaction of nanoparticles (NPs) with biological
systems including living cells has become one of the most
crucial areas of research in materials science and biology.
In our study the effect of spherical AuNPs (average
diameters of 25-50 nm) on cell viability and on biomarkers
involved in wound healing in NHDF and NHEK was
tested. Accurate size and shape of AuNPs were determined
by transmission electron microscopy (TEM) (Fig. 1B). The
TEM analysis revealed that AuNPs have spherical mor‐
Figure 1. A Particle size distribution; B characterization of AuNPs by transmission electron microscopy (TEM)
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phology (Fig. 1). The size distribution analysis showed 29%
of the AuNPs occurring between 25-50 nm in size (Fig. 1A).
It was shown that AuNPs have many side effects due to the
interaction with cell membrane, mitochondria, or nucleus.
One recent study has shown toxicity of AuNPs to be related
to dose, surface charge and area [22]. It has also been
reported that the surface charge is one of the major factors
influencing AuNPs’ toxicity [23]. Several studies have
compared the toxicity of AuNPs (2 nm) with positively and
negatively charged surface. It has been found that nega‐
tively charged AuNPs had IC50 >7.37 µmol/l for monkey
fibroblast cell lines (Cos-1) and IC50 for red blood cells was
72 µmol/l, while positively charged ones had IC50 1 µmol/
l for both types of cell under the same condition. The higher
toxicity of positively charged AuNPs was explained by
their ability to interact with the negatively charged cellular
membrane [15]. On the other hand it was demonstrated that
AuNPs (1.5 nm) charged both positively and negatively
were toxic on HaCaT cell lines at the concentration of 10
µg/ml [24]. In our study toxicity of negatively charged
AuNPs (-23.4 mV) was evaluated by cell viability MTT
assay after 24 hrs. It was shown that AuNPs do not have a
significant cytotoxic effect on NHDF (0.01-25 ppm) (Fig.
2A) and NHEK (0.013-33 ppm) (Fig. 2B) at any concentra‐
tions. However, NHEK was more sensitive to AuNPs
because they showed lower viability compared to NHDF.
Others factors, such as ionic strength, size, shape and
stabilizer can also affect the toxicity of AuNPs. It has been
found that spherical AuNPs (21 nm) stabilized by citrate
does not have a toxic effect on human breast-cancer cell
lines (MCF-7) or human prostate-cancer cell lines (PC-3). It
has also been reported that spherical AuNPs (10-50 nm)
stabilized by citrate were not toxic to human leukemic cells
(K562) and NHDF. These results are in line with our
findings whereby spherical AuNPs (average diameter of
25-50 nm) stabilized by sodium citrate were not signifi‐
cantly toxic to NHDF or NHEK [25, 23].
Some studies have demonstrated that AuNPs induce the
release of a number of pro-inflammatory markers in bone-
marrow dendritic cells and in macrophages. In vivo studies
have shown that AuNPs exhibited anti-inflammatory
properties via decreasing of the pro-inflammatory cyto‐
kines such as IL-6 and TNF-α due to the inhibition of
nuclear factor kappa-B (NF-kB) activation [26, 27].
AuNPs may also have characteristic properties according
to their size. It has also been shown that AuNPs (40 nm)
stimulated pro-inflammatory cytokines IL-6, IL-12 and
TNF-α, but smaller AuNPs (20 nm) did not induce any
intense changes in the levels of pro-inflammatory markers
[18]. Our results showed that AuNPs (25-50 nm) were more
active in NHDF (Fig. 3) than in NHEK (Fig. 4). It was found
that AuNPs at the concentration of 2.5 ppm decreased the
production of IL-12, VEGF and bFGF after 24 hrs (Fig. 3A)
and IL-12, VEGF, bFGF, and TNF-α after 48 hrs (Fig. 3B) in
NHDF. Moreover, higher concentrations of AuNPs (25
ppm) decreased level of IL-8 and VEGF after 24 hrs (Fig.
3A) and IL-12, VEGF, GM-CSF and TNF-α after 48 hrs (Fig.
3B) in NHDF. Meanwhile, in NHEK AuNPs at concentra‐
tions of 2.5 and 25 ppm were effective only after 24 hrs. It
was found that AuNPs at 2.5 ppm decreased the produc‐
tion of IL-6 and MMP-1 and the higher concentration of 25
ppm decreased levels of VEGF and TNF-α (Fig. 4A, B).
However, in our work, the size of AuNPs is not uniform.
Therefore, we cannot compare our results in terms of size
of AuNPs.
Besides anti-inflammatory activity, AuNPs were found to
have anti-angiogenic effects. It has been shown that AuNPs
interact with the sulphur/amines present in the heparin-
binding domain of VEGF165 [28]. It has also been indicated
that AuNPs inhibit VEGF121 by changing its conformation
[29]. These results are in agreement with our study, where
we determined that AuNPs decrease the level of VEGF in
both cell cultures, NHDF and NHEK. Moreover, it is known
that bFGF is an angiogenic agent and has affinity for
heparin like VEGF [30]. We found that AuNPs also de‐
creased the level of bFGF in NHDF. This effect of AuNPs
may be beneficial for the treatment of cancer due to the
inhibition of angiogenesis.
Figure 2. A Cytotoxicity of AuNPs on NHDF; B cytotoxicity of AuNPs on NHEK
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Figure 3. Effects of AuNPs on wound-healing markers in NHDF after 24 hrs (A) and 48 hrs (B). Control was scratch cells incubated in serum-free medium
without AuNPs; an asterix (*) indicates statistically significant difference from the control (*p<0.05; **p<0.01; ***p<0.001).
Figure 4. Effects of AuNPs on wound-healing markers in NHEK after 24 hrs (A) and 48 hrs (B). Control was scratch cells incubated in serum-free medium
without AuNPs; an asterix (*) indicates statistically significant difference from the control (*p<0.05; **p<0.01).
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4. Conclusion
Our study showed that AuNPs (average diameter 25-50
nm) with negatively charged surface (-23.4 mV) were not
toxic to NHDF and NHEK. In addition, they exerted anti-
inflammatory activity via inhibition of IL-6, IL-12 and TNF-
α level, and anti-angiogenic activity decreasing the
expression of VEGF and bFGF. These properties are of
clinical significance and contribute to the application of
AuNPs in biomedicine. The anti-angiogenic activity can be
exploited for cancer therapy [10]. In addition, cutaneous
wounds, diabetic wound tissue, and rheumatoid arthritis
can be treated with AuNPs due to their anti-inflammatory
properties [10, 31, 32].
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